
Precipio PRPO
$ 24.35
-2.42%
Quarterly report 2025-Q3
added 11-14-2025
Precipio Operating Cycle 2011-2025 | PRPO
Annual Operating Cycle Precipio
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 49.8 | 67.2 | 58.2 | 78.2 | 90.1 | 115 | 196 | 57.7 | 67.7 | 166 | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 196 | 49.8 | 94.6 |
Quarterly Operating Cycle Precipio
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 45.6 | 46.5 | 41.8 | - | 38 | 40.5 | 46 | - | 44.2 | 45.4 | 58.4 | - | 76.4 | 77.6 | 62.9 | - | 53.4 | 50.2 | 65.2 | - | 74.6 | 89.1 | 76.7 | - | 89 | 77.4 | 107 | - | 124 | 105 | 115 | - | 289 | 308 | 143 | - | 117 | 78.9 | 101 | - | 83.2 | 64.3 | 49.3 | 34.7 | 274 | 166 | 179 | 78 | 159 | 150 | 183 | 101 | 207 | 184 | 199 | 80.6 | 176 | 203 | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 308 | 34.7 | 110 |
Operating Cycle of other stocks in the Diagnostics research industry
| Issuer | Operating Cycle | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
170 | - | -6.23 % | $ 30.6 M | ||
|
Akumin
AKU
|
57.4 | - | -17.87 % | $ 25.9 M | ||
|
Burning Rock Biotech Limited
BNR
|
275 | $ 16.36 | -4.05 % | $ 176 M | ||
|
Accelerate Diagnostics
AXDX
|
489 | - | -61.36 % | $ 2.46 M | ||
|
Biocept
BIOC
|
134 | - | -13.05 % | $ 7.29 M | ||
|
BioNano Genomics
BNGO
|
329 | $ 1.63 | -2.11 % | $ 2.07 M | ||
|
Chembio Diagnostics
CEMI
|
164 | - | 0.22 % | $ 16.8 M | ||
|
IQVIA Holdings
IQV
|
78 | $ 221.54 | -1.96 % | $ 40.2 B | ||
|
Castle Biosciences
CSTL
|
97.9 | $ 38.85 | 2.32 % | $ 1.08 B | ||
|
Global Cord Blood Corporation
CO
|
202 | - | - | $ 399 M | ||
|
Genetic Technologies Limited
GENE
|
11.8 K | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
185 | - | 0.12 % | $ 80.1 M | ||
|
Danaher Corporation
DHR
|
150 | $ 227.08 | -2.28 % | $ 166 B | ||
|
DermTech
DMTK
|
114 | - | -11.32 % | $ 2.94 M | ||
|
PRA Health Sciences, Inc.
PRAH
|
1.22 K | - | - | $ 10.7 B | ||
|
DarioHealth Corp.
DRIO
|
251 | $ 11.92 | -6.58 % | $ 338 M | ||
|
DexCom
DXCM
|
204 | $ 66.91 | -2.94 % | $ 25.8 B | ||
|
CareDx, Inc
CDNA
|
76.4 | $ 20.44 | 3.23 % | $ 1.1 B | ||
|
Enzo Biochem
ENZ
|
206 | - | -8.98 % | $ 14.8 K | ||
|
Anixa Biosciences
ANIX
|
385 | $ 3.59 | -25.21 % | $ 115 K | ||
|
Exact Sciences Corporation
EXAS
|
269 | $ 101.58 | 0.21 % | $ 18.8 B | ||
|
Co-Diagnostics
CODX
|
405 | $ 0.34 | -2.96 % | $ 9.98 M | ||
|
Fulgent Genetics
FLGT
|
77.4 | $ 27.13 | 0.26 % | $ 820 M | ||
|
Guardant Health
GH
|
49.1 | $ 102.09 | 0.7 % | $ 12.5 B | ||
|
Aspira Women's Health
AWH
|
73.8 | - | -6.19 % | $ 10.5 M | ||
|
Koninklijke Philips N.V.
PHG
|
89 | $ 26.6 | -1.52 % | $ 20 B | ||
|
Heska Corporation
HSKA
|
177 | - | - | $ 1.31 B | ||
|
HTG Molecular Diagnostics
HTGM
|
216 | - | -20.0 % | $ 1.06 M | ||
|
Illumina
ILMN
|
198 | $ 134.29 | -1.58 % | $ 21.4 B | ||
|
Charles River Laboratories International
CRL
|
67.7 | $ 192.57 | -0.96 % | $ 9.89 B | ||
|
Quidel Corporation
QDEL
|
68.4 | $ 28.79 | -2.93 % | $ 1.21 B | ||
|
Quotient Limited
QTNT
|
432 | - | -11.32 % | $ 1.1 M | ||
|
Quest Diagnostics Incorporated
DGX
|
56.9 | $ 182.21 | 0.35 % | $ 20.2 B | ||
|
Biodesix
BDSX
|
41.7 | $ 7.94 | -1.0 % | $ 1.03 B | ||
|
Laboratory Corporation of America Holdings
LH
|
72.9 | $ 263.51 | -0.46 % | $ 22.1 B | ||
|
ICON Public Limited Company
ICLR
|
68.5 | $ 186.28 | -1.92 % | $ 15.4 B | ||
|
IDEXX Laboratories
IDXX
|
135 | $ 701.07 | -0.91 % | $ 57.8 B | ||
|
Lantheus Holdings
LNTH
|
116 | $ 66.11 | 4.76 % | $ 4.57 B | ||
|
Agilent Technologies
A
|
161 | $ 139.44 | -2.4 % | $ 42.4 B | ||
|
Biomerica
BMRA
|
204 | $ 2.55 | -1.07 % | $ 5.86 M | ||
|
Bioventus
BVS
|
267 | $ 7.59 | 2.29 % | $ 475 M | ||
|
Motus GI Holdings
MOTS
|
3.45 K | - | -34.28 % | $ 263 K | ||
|
Mettler-Toledo International
MTD
|
63.7 | $ 1 395.23 | -1.85 % | $ 29.6 B | ||
|
Myriad Genetics
MYGN
|
87.1 | $ 7.26 | -0.62 % | $ 658 M | ||
|
ENDRA Life Sciences
NDRA
|
412 | $ 5.47 | -7.6 % | $ 2.94 M |